Connect with us

Media & Technology

Roshan Lithium, Nevada EV Facility; BRLL (Barrel Energy) Major League Run

Published

on

BRLL is making a spectacular run up the charts since we reported on the stock several weeks back when the stock was well under a dime. Since than BRLL has exploded upwards to recent highs of $0.85 per share transforming into a volume leader in small caps trading $40 million plus on Thursday alone and attracting legions of new shareholders who continue to bid the stock higher. Microcapdaily noted on BRLL before it took off that the stock had a tight share structure with just 291 million shares outstanding and AS capped at 450 million. 

There is a lot to get excited about on BRLL; the Company just opened up its research and technology center in Las Vegas, NV situated on a roughly 30-acre property that is now zoned for industrial activities located in Nevada just 18.5 miles from the Tesla Gigafactory 1. The facility will strengthen Barrels’ green-energy and Electric Vehicles (EVs) product development and various collaborative technology efforts. Barrel recognizes the current deficiencies, as well as the massive potential, in the Lithium-ion battery supply chain as market and environmental forces propel the coming dominance of Zero-Emission vehicles with companies like Tesla, GM, Ford, Apple and others drive this vital technology. BRLL just signed an MOU for a partnership with Roshan Energy Technologies Pvt. Ltd located in Hyderabad, India, for Lithium Battery development and production in India and North America. As part of the venture, Barrel will become a majority stakeholder in Roshan allowing Barrel Energy the platform for expansion into the massive India market and into international markets. Roshan and Barrel plan on establishing a U.S. based manufacturing unit for key battery designs within Roshan’s line of Lithium products. India is at the forefront of innovation and technology and represents one of the largest markets for Electric Vehicles (EVs) worldwide with plans to become an all-EV nation by 2030 

Barrel Energy Inc (OTCMKTS: BRLL) is focused on several ventures within the energy and minerals sector and the rapid development of valuable production opportunities throughout North America. The Company is led by CEO Craig Alford who took the helm of Oroplata this month, soon after the announcement of the exploration results in the WNB. He has 30 years of experience in the mining industry, having managed an extensive number of projects across the world, from China to Australia, and from North and South America to Africa. Alford held senior positions in several leading miners such as Zijin, Teck Mining, and served as assistant to the World Bank and the China-Africa Development Fund on issues including investment risk, planning, and tax policy. On 8 July, Oroplata also officially brought on Paul Pelosi Jr. as senior advisor. Pelosi is the son of former U.S. Speaker of the House Nancy Pelosi, and he has extensive experience advising Fortune 500 companies in environmental sustainability and public policy. He also advises NASA Ames Research Center, and is a founding member of Cisco Systems Connected Urban Development. Currently Craig Alford is assisting Altair International Corp. to develop ATAO’s prized lithium/rare earth and gold assets in Nevada. Mr. Alford was also the founder of American Battery Metals Corp

Microcapdaily reported on BRLL on January 31 when the stock was a dime. We reported on BRLL CEO Mr. Craig Alford who at this time is assisting Altair International Corp. (ATAO: OTC) to develop ATAO’s prized lithium/rare earth and gold assets in Nevada. Mr. Alford was also the founder of American Battery Metals Corp. The Chairman of Barrel Energy, Mr. Harp Sangha and Mr. Alford are also the founders of Lithium Now. Barrel is in discussions with St-Georges Eco-Mining Corp a Canadian public company engaged in the development of new Lithium extraction technologies regarding several sites for their Lithium processing technology centers within the southwest U.S. The Company is considering location sites with a specific eye toward cost efficiency and process permitting. Access to infrastructure, sufficient power, transport and nearby source material and demand are all factors for project viability. The Company’s lead development site is situated on a roughly 30-acre property that is now zoned for industrial activities located in Nevada just 18.5 miles from the Tesla Gigafactory 1. 

The demand for lithium is growing exponentially; according to Vinneth Bajaj, a senior mining analyst for GlobalData: “Lithium metal production is expected to reach 134,700 tonnes versus 58,800 tonnes in 2020. Tthe Global Lithium-Ion Battery Recycling Market is valued at USD 8.81 Billion in 2020 and expected to reach USD 14.34 Billion by 2027 with the CAGR of 7.20% over the forecast period. 

To Find out the inside Scoop on BRLL Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

BRLL

BRLL has had a big week! On Monday the Company reported the opening of its research and technology center in Las Vegas, NV. The facility will strengthen Barrels’ green-energy product development and various collaborative technology efforts. Barrel recognizes the current deficiencies, as well as the massive potential, in the Lithium-ion battery supply chain as market and environmental forces propel the coming dominance of Zero-Emission vehicles with companies like Tesla, GM, Ford, Apple and others drive this vital technology. Despite their current market share, Electric Vehicles (EVs) are currently the fastest growing segment of the auto industry. 

The new center will be the focus for Barrel’s efforts into Lithium-Ion Battery metal recycling as well as potential battery development and direct metal ion extraction. Barrel intends to immerse itself into the key materials and technology that will underpin this decades coming surge in EV dominance. Additionally, a section of the center will be dedicated to developmental support and on-site innovative I.P. efforts as Barrel finalizes its discussions with a number of next-level software and related technology partnerships.   

On February 10 BRLL announced it has signed a Memorandum of Understanding to enter a partnership with Roshan Energy Technologies Pvt. Ltd located in Hyderabad, India, for Lithium Battery development and production in India and North America. As part of the venture, Barrel will become a majority stakeholder in Roshan allowing Barrel Energy the platform for expansion into the massive India market and into international markets. Roshan and Barrel plan on establishing a U.S. based manufacturing unit for key battery designs within Roshan’s line of Lithium products. 

A joint R&D division will be developed in conjunction with Barrels’ Nevada Tech Center as part of the partnership. Roshan’s Ashok Shukla, a professor emeritus with 40 years’ research experience of specialized batteries and over 350 published technical papers will lead the team with the aim of designing customized solutions for battery development, improvement, and recycling. As part of this transformative deal, Roshan and Barrel will first establish a Lithium Battery Manufacturing facility in India. Plans for the facility with a three phase roll out of powerful products has been in development by Roshan’s CEO and engineering team leader, Mr. S.A. Gaffoor. Mr. Gaffoor, a veteran electrical Engineer and entrepreneur, has over 25 years in designing and developing industrial battery products and holds 10 patents for advanced battery technologies.   

India is a nation on the forefront of innovation and technology and represents one of the largest markets for Electric Vehicles (EVs) worldwide with plans to become an all-EV nation by 2030. Roshan has already developed strong partnerships in China with deals with Guangzhou Great Power Energy & Technology Co (http://www.greatpower.net) and Suzhou Chilwee New Energy Power Technology Co. (http://www.sz-cpet.com/en/) and has a impressive line of Lithium Battery products for EVs, Medical Equipment, Solar street lighting, the telecom industry as well as medium and large energy storage. 

For More on BRLL Subscribe Right Now!

BRLL is making a spectacular run up the charts since we reported on the stock several weeks back when the stock was well under a dime. Since than BRLL has exploded upwards to recent highs of $0.85 per share transforming into a volume leader in small caps trading $40 million plus on Thursday alone and attracting legions of new shareholders who continue to bid the stock higher. Microcapdaily noted on BRLL before it took off that the stock had a tight share structure with just 291 million shares outstanding and AS capped at 450 million.  There is a lot to get excited about on BRLL; the Company just opened up its research and technology center in Las Vegas, NV situated on a roughly 30-acre property that is now zoned for industrial activities located in Nevada just 18.5 miles from the Tesla Gigafactory 1. The facility will strengthen Barrels’ green-energy and Electric Vehicles (EVs) product development and various collaborative technology efforts. Barrel recognizes the current deficiencies, as well as the massive potential, in the Lithium-ion battery supply chain as market and environmental forces propel the coming dominance of Zero-Emission vehicles with companies like Tesla, GM, Ford, Apple and others drive this vital technology. BRLL just signed an MOU for a partnership with Roshan Energy Technologies Pvt. Ltd located in Hyderabad, India, for Lithium Battery development and production in India and North America. As part of the venture, Barrel will become a majority stakeholder in Roshan allowing Barrel Energy the platform for expansion into the massive India market and into international markets. Roshan and Barrel plan on establishing a U.S. based manufacturing unit for key battery designs within Roshan’s line of Lithium products. India is at the forefront of innovation and technology and represents one of the largest markets for Electric Vehicles (EVs) worldwide with plans to become an all-EV nation by 2030. We will be updating on BRLL when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with BRLL.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in BRLL  either long or short and we have not been compensated for this article.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

LAVA Therapeutics (NASDAQ: LVTX) Gammabody™ Platform Gains Momentum

Published

on

LAVA Therapeutics N.V. (NASDAQ: LVTX) shares soared 106% as the company announced that Janssen Biotech, Inc. chose a lead candidate.

LAVA Therapeutics N.V. (NASDAQ: LVTX) shares soared 106% as the company announced that Janssen Biotech, Inc., a part of the Janssen Pharmaceutical Companies of Johnson & Johnson, chose a lead candidate aimed at an undisclosed tumor-associated antigen for further development towards clinical settings.

GAMMABODY™ PLATFORM

LAVA primarily focuses on revolutionizing cancer therapy by developing its Gammabody™ platform. This platform enables them to create bispecific gamma delta T cell engagers that can activate a specific subset of gamma-delta T cells called Vγ9Vδ2 (Vgamma9 Vdelta2) T cells. By utilizing this approach, they aim to enhance the natural recognition of tumors, guide Vγ9Vδ2 T cells to target the tumor cells directly and trigger a cascade of immune responses.

To Discover the Inside Scoop on LVTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

What sets their Gammabody™ drug candidates apart is their exceptional performance and safety profiles observed in preclinical studies. Compared to other bispecific T cell engager approaches, their candidates have demonstrated superior efficacy and preferred targeting tumor cells. This targeted approach has the potential to minimize toxicity in healthy tissues.

In May 2020, LAVA entered into a research collaboration and license agreement with Janssen, a subsidiary of the Janssen Pharmaceutical Companies of Johnson & Johnson. This collaboration aimed to discover and develop novel bispecific antibody-based gamma delta T cell engagers for cancer treatment. The agreement was facilitated by Johnson & Johnson Innovation, emphasizing their commitment to fostering innovation in the field.

As part of the collaboration, LAVA had the opportunity to receive potential milestone payments and royalties based on the successful development, regulatory approvals, and commercialization of the candidates. This incentivized LAVA to actively pursue the discovery and advancement of promising lead candidates. 

The collaboration represents a remarkable milestone many early-stage biotech companies aspire to achieve. Partnering with a program brings numerous benefits, including reduced risk of dilution through milestone payments as the trials advance and streamlined commercialization once the product receives approval.

Under the terms of the agreement, Janssen will assume responsibility for the selected candidate’s future clinical development, manufacturing, and commercialization. This includes bearing the costs and expenses associated with these activities.

Stephen Hurly, LAVA Therapeutics’s president and chief executive officer, expressed satisfaction with Janssen’s selection of a lead candidate for clinical studies. He emphasized LAVA’s pioneering role in developing gamma-delta bispecific antibodies through their proprietary Gammabody platform. This platform and LAVA’s extensive expertise in bispecific antibody development position them at the forefront of advancing novel therapies for cancer patients.

In summary, LAVA Therapeutics’ collaboration with Janssen has reached a significant milestone in selecting a lead candidate for further development toward clinical studies. This progress underscores LAVA’s dedication to leveraging its Gammabody platform and expertise in bispecific antibody development to revolutionize cancer treatment.

We will update you on LVTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Continue Reading

Featured

Onfolio Holdings (NASDAQ: ONFO) Unleashing the Power of AI

Published

on

Onfolio Holdings Inc (NASDAQ: ONFO), a technology services company, has recently introduced an advanced generative AI search function for its subsidiary, MightyDeals.com.

Onfolio Holdings Inc (NASDAQ: ONFO), a technology services company, has recently introduced an advanced generative AI search function for its subsidiary, MightyDeals.com. The implementation of this innovative AI tool, powered by chatGPT-style Large Language Models (LLMs), has resulted in a surge of 105% in the company’s stock price and sparked tons of investor interest. The company has a 3.28M float and, at the time of writing, has traded 20x that amount, with a colossal 60M shares exchanging hands.

Revolutionizing User Experience and Driving Stock Surge

With the integration of AI search on MightyDeals.com, customers can now use natural language to describe the products they seek, simplifying the buying process. The AI tool utilizes contextual understanding and description analysis of hundreds of active deals to generate instant search results based on users’ queries. By enhancing the user experience, Onfolio Holdings anticipates increased user return rates, higher site interaction rates, and elevated revenues for MightyDeals.com. This groundbreaking development has attracted positive attention, significantly increasing Onfolio Holdings’ stock price.

To Discover the Inside Scoop on ONFO, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Evaluating Financial Performance

While the stock surge indicates investor enthusiasm, assessing Onfolio Holdings’ financial performance is crucial for comprehensive investment analysis. The positive earnings growth of +44.44% and revenue growth of +22.74% contribute to the company’s optimistic outlook. However, investors should be cautious of the negative net profit margin of -190.75% and the lack of available price/book ratio data. Monitoring the company’s financial performance leading up to the next reporting date on August 30, 2023, is advised to understand its profitability and overall stability better.

Investment Outlook and Future Prospects

Considering the stock surge and optimistic price forecasts, Onfolio Holdings has promising prospects. Analysts offer a median target price of $3.00 for the company’s stock, signaling an expectation of significant growth within the next 12 months. However, it is essential to note that Onfolio Holdings operates at a loss. Investors should thoroughly evaluate the company’s long-term growth potential and weigh the potential returns against the inherent risks before making investment decisions.

About MightyDeals.com

Mighty Deals is a free daily deals website aimed at creative professionals focusing on products and services for web designers and developers. The site offers fantastic deals on quality fonts, templates, apps, add-ons, plug-ins, ebooks, icons, and more. The site provides discounts on packages which usually range between 50%-97% off but are only available for a limited time. MightyDeals.com boasts an exceptional return rate from its users and is one of Onfolio Holdings’ highest revenue-generating subsidiaries.

About Onfolio Holdings Inc.

Onfolio acquires and manages a diversified portfolio of online businesses across a broad range of verticals, each with a niche content focus and brand identity. Onfolio acquires firms that meet its investment criteria, being that such businesses operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by our existing team or have strong management teams largely in place. The Company excels at finding acquisition opportunities where the seller has not fully optimized their business. Onfolio’s experience and skillset allow it to add increased value to these existing businesses.

Conclusion

Onfolio Holdings’ introduction of the generative AI search function for MightyDeals.com has increased the company’s stock price, reflecting the market’s positive response to this innovative technology. The enhanced user experience and the potential for increased revenues have positioned Onfolio Holdings as a leader in the tech industry. However, investors must carefully consider the company’s financial performance and evaluate its long-term growth potential before making investment decisions. Monitoring the company’s performance to the next reporting date will provide valuable insights into its financial health and stability.

We will update you on ONFO when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by James from Pixabay

Continue Reading

Featured

Enveric Biosciences (NASDAQ: ENVB) Pioneering the Future of Anxiety Disorder Treatment

Published

on

Enveric Biosciences, Inc. (NASDAQ: ENVB) shares surged 78% this morning upon approval of some fantastic news.

Enveric Biosciences, Inc. (NASDAQ: ENVB) shares surged 78% this morning upon approval of some fantastic news. The United States Patent and Trademark Office has granted them a notice of allowance for their patent application concerning a groundbreaking chemical compound called EB-373. This compound is being developed to address the treatment of anxiety disorders.

The forthcoming patent, titled “C4-Carbonothioate-Substituted Tryptamine Derivatives and Methods of Using,” encompasses claims for the composition of matter of a family of revolutionary prodrug derivatives of psilocin. Enveric’s lead product candidate, EB-373, stands out among these derivatives. A Notice of Allowance signifies that the USPTO has determined that a patent should be granted based on the submitted application.

To Discover the Inside Scoop on ENVB, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Enveric’s commitment to innovation extends beyond EB-373. They have also submitted additional patent applications to the USPTO, exploring psilocin prodrugs with unique crystalline molecular structures. Moreover, they have taken proactive steps to pursue global coverage of the EVM201 and EVM301 Series through companion Patent Cooperation Treaty and non-US national patent applications. Encouragingly, positive International Search Reports and written opinions have been received under the Patent Cooperation Treaty for most of these applications.

Joseph Tucker, Ph.D., Enveric’s director and CEO, underlined the significance of the USPTO’s favorable decision concerning their lead candidate, EB-373. He highlighted the innovative designs of their psilocin prodrugs within the EVM201 series, differentiating them from conventional counterparts like psilocybin. These novel designs hold the potential to deliver more rapid therapeutic effects, precise control, and reduced gastrointestinal side effects. Tucker emphasized that securing a robust intellectual property portfolio for their new chemical entity prodrugs is pivotal to Enveric’s value proposition and integral to their business strategy of developing cutting-edge small-molecule therapeutics to address mental health disorders.

We will update you on ENVB when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gino Crescoli from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.